Skip to main content
Advertisement
Advertisement

NMTC

NMTC logo

NeuroOne Medical Technologies Corporation Common Stock

1.38
USD
Sponsored
+0.08
+6.15%
Sep 22, 15:59 UTC -4
Closed
exchange

Pre-Market

1.48

+0.10
+6.88%

NMTC Earnings Reports

Positive Surprise Ratio

NMTC beat 14 of 19 last estimates.

74%

Next Report

Date of Next Report
Dec 15, 2026
Estimate for Q4 26 (Revenue/ EPS)
$2.86M
/
-$0.23
Implied change from Q3 26 (Revenue/ EPS)
+45.11%
/
--
Implied change from Q4 25 (Revenue/ EPS)
-1.02%
/
-4.17%

NeuroOne Medical Technologies Corporation Common Stock earnings per share and revenue

On Aug 13, 2026, NMTC reported earnings of -0.23 USD per share (EPS) for Q3 26, missing the estimate of -0.22 USD, resulting in a -4.07% surprise. Revenue reached 1.97 million, compared to an expected 2.60 million, with a -24.06% difference. The market reacted with a +20.39% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 4 analysts forecast an EPS of -0.23 USD, with revenue projected to reach 2.86 million USD, implying an increase of 0.00% EPS, and increase of 45.11% in Revenue from the last quarter.
FAQ
For Q3 2026, NeuroOne Medical Technologies Corporation Common Stock reported EPS of -$0.23, missing estimates by -4.07%, and revenue of $1.97M, -24.06% below expectations.
The stock price moved up 20.39%, changed from $1.52 before the earnings release to $1.83 the day after.
The next earning report is scheduled for Dec 15, 2026.
Based on 4 analysts, NeuroOne Medical Technologies Corporation Common Stock is expected to report EPS of -$0.23 and revenue of $2.86M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement